SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s
On February 27, 2004, the FDA approved the oral version of Novartis Pharmaceuticals Corporation's immunosuppressant Myfortic (mycophenolic acid), allo...
Actavis Labs FL Inc. secured FDA approval for its generic product, bolstering its financial outlook by expanding its portfolio in a highly competitive...
Watson Labs received an FDA approval that is expected to enhance revenue growth as the company prepares to launch a new generic product. This approval...
# FDA Approves AstraZeneca's CRESTOR (rosuvastatin calcium) for Cholesterol Management AstraZeneca Pharmaceuticals LP has received FDA approval for C...
# FDA Approves Fresenius Kabi's Intravenous Valproate Sodium Formulation Fresenius Kabi USA, LLC received FDA approval for its intravenous valproate ...
Genentech’s (CHI.HS) FDA approval of its subcutaneous administration of OMALIZUMAB for XOLAIR in June 2003 launched a blockbuster franchise that revol...
# FDA Approves Amneal Pharmaceuticals' Epinephrine Injection Amneal Pharmaceuticals of New York LLC has received FDA approval for its subcutaneous ep...
Novartis Pharmaceuticals marked a decisive revenue milestone with the FDA approval of the blockbuster oncology agent Gleevec in 2003, a pivotal advanc...
Uronova Pharmaceuticals announced the FDA approval of Vabrimty, a generic Leuprolide Acetate injection, which positions the company to compete directl...
Prasco Laboratories' earlier approval of the synthetic peptide teriparatide establishes a foundational market presence for the osteoporosis treatment,...
Eli Lilly and Company has announced that the capsule form of its branded attention deficit hyperactivity disorder (ADHD) medication STRATTERA (atomoxe...
# FDA Approves Sagent Pharmaceuticals' Intravenous Valproate Sodium Formulation Sagent Pharmaceuticals has received FDA approval for its intravenous ...
USAntibiotics, LLC announced on Tuesday that the FDA has granted approval for AMOXICILLIN AND CLAVULANATE POTASSIUM, oral dosage form NDA050785, with ...
Uronova Pharmaceuticals announced the FDA approval of VABRINTY (Leuprolide Acetate) Subcutaneous for Autoinjector, continuing the company’s strategy o...
Amneal Pharmaceuticals NY LLC announced the approval of its ANDA for tramadol hydrochloride oral tablet from the FDA, initiating commercialization of ...
Teva Pharmaceuticals USA, Inc. received FDA approval for generic Tramadol Hydrochloride tablets, a development likely to intensify generic competition...
# FDA Approves Roerig's VFEND (voriconazole) for Invasive Fungal Infections Roerig has received FDA approval for VFEND (voriconazole), an oral antifu...
On April 23, 2002, Apotex announced approval for its abbreviated new drug application (ANDA075984), signaling its entry into the pharma market. This r...
PHARMOBEDIENT received FDA approval for its ANDA on April 22, 2002, position the company to capture market share and increase competition within the r...
Hikma Pharmaceuticals USA Inc. secured FDA approval for its generic nasal butorphanol tartrate product, reinforcing its strategic expansion within the...